LIVN News and Press, LivaNova PLC From 04/27/20

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for E...

Various products can now be used to treat patients experiencing acute respiratory or cardiopulmonary failure LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that several of its cardiopulmonary products are now permitted to be used...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2020 results on Wednesday, April 29, 2020 at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its first quarter 2020 resu...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology for patients with heart failure will be shared at this year’s American College of Cardiology and World Congress of Ca...

This article is first in a series that provides an ongoing analysis of the changes made to Harris Associates' 13F stock portfolio on a quarterly basis. It is based on Harris Associates’ regulatory 13F Form filed on 02/14/2020. William Nygren’s 13F portfolio value increased ~10%...

Two UK patients receive innovative VNS Therapy implantable device through new pathway LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy ® (VNS Therapy) System, Symmetry™, earned CE Ma...

Image source: The Motley Fool. LivaNova PLC   (NASDAQ: LIVN) Q4 2019 Earnings Call Feb 26, 2020 , 8:00 a.m. ET Operator Continue reading

RECOVER sub-study will leverage Verily research tools to provide quantitative assessment measures of depressive episodes LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a research collaboration with Verily, an Alphabet company, to...

LivaNova PLC (LIVN) Q4 2019 Earnings Conference Call February 26, 2020 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice President ...

The following slide deck was published by LivaNova PLC in conjunction with their 2019 Q4 earnings Read more ...